Loading company
Loading
Open Financials Bioverativ Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2017 | FY2016 | Change | Source |
|---|---|---|---|---|
| Revenue | $1.2 billion | $887.4 million | +31.7% | 10-K 2018-02-14 · proof |
| Gross profit | $888.9 million | $649.5 million | +36.9% | 10-K 2018-02-14 · proof |
| Operating income | $447.2 million | $292.4 million | +52.9% | 10-K 2018-02-14 · proof |
| Net income | $355.6 million | $439.6 million | -19.1% | 10-K 2018-02-14 · proof |
| Cash from operating activities | $590.7 million | $301.6 million | +95.9% | 10-K 2018-02-14 · proof |
| Free cash flow | $577.6 million | $292.9 million | +97.2% | 10-K 2018-02-14 · proof |
- What was Bioverativ Inc.'s revenue in fiscal 2017?
- Bioverativ Inc. reported revenue of $1.2 billion for fiscal 2017 (the year ended Dec 31, 2017), against $887.4 million the year before (+31.7%). Source: the 10-K filed with the SEC on Feb 14, 2018. SEC
- What was Bioverativ Inc.'s gross profit in fiscal 2017?
- Bioverativ Inc. reported gross profit of $888.9 million for fiscal 2017 (the year ended Dec 31, 2017), against $649.5 million the year before (+36.9%). Source: the 10-K filed with the SEC on Feb 14, 2018. SEC
- What was Bioverativ Inc.'s operating income in fiscal 2017?
- Bioverativ Inc. reported operating income of $447.2 million for fiscal 2017 (the year ended Dec 31, 2017), against $292.4 million the year before (+52.9%). Source: the 10-K filed with the SEC on Feb 14, 2018. SEC
- What was Bioverativ Inc.'s net income in fiscal 2017?
- Bioverativ Inc. reported net income of $355.6 million for fiscal 2017 (the year ended Dec 31, 2017), against $439.6 million the year before (-19.1%). Source: the 10-K filed with the SEC on Feb 14, 2018. SEC
- What was Bioverativ Inc.'s cash from operating activities in fiscal 2017?
- Bioverativ Inc. reported cash from operating activities of $590.7 million for fiscal 2017 (the year ended Dec 31, 2017), against $301.6 million the year before (+95.9%). Source: the 10-K filed with the SEC on Feb 14, 2018. SEC
- What was Bioverativ Inc.'s free cash flow in fiscal 2017?
- Bioverativ Inc. reported free cash flow of $577.6 million for fiscal 2017 (the year ended Dec 31, 2017), against $292.9 million the year before (+97.2%). Source: the 10-K filed with the SEC on Feb 14, 2018. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1681689&period_type=annual&limit=5"Information only, not investment advice.